Clinical trial
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With…
NCT00123903 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00123903 |
|---|---|
| Title | COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria |
| Official title | A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive and Microalbuminuria |
| Intervention type | Drug |
| Interventions | metoprolol xl, carvedilol MR, lisinopril |
| Enrollment | 1,220 |
| Start date | Jul 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jul 26, 2005 |
| Last update posted | Jan 18, 2017 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: